COMPANY OVERVIEW

F2G is an established UK Biotech focusing on the discovery and development of novel drugs to treat life threatening fungal diseases

---

LOCATION

Eccles, Manchester, UK

---

THERAPEUTIC AREAS

Infectious Disease

---

WEBSITE

https://f2g.com

---

CAREER WEBSITE

https://www.f2g.com/careers/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Aug 4, 2022

F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim

May 16, 2022

Shionogi and Co., Ltd. and F2G Ltd., Enter Strategic Collaboration to Develop and Commercialize the New Antifungal Agent Olorofim in Europe and Asia

May 16, 2022

Novo Holdings Portfolio Company F2G enters strategic collaboration with Shionogi to commercialise its new antifungal agent Olorofim in Europe and Asia

Sep 15, 2021

F2G appoints Camilla Soenderby to Board of Directors

Apr 12, 2021

Francesco Maria Lavino appointed Chief Executive Officer of F2G Ltd

For More Press Releases

---